Companies / Romania
Antibiotice Suitors Emerge
December 2006 | Company News AlertThe first of many companies interested in Romania's largest drugmaker Antibiotice have revealed their intentions to acquire the majority stake held by the state. The highest profile party is Icelandic raider Actavis, which has a strategy of "cherry-picking" small pharmaceutical companies in promising emerging markets. Among the other confirmed bidders are the local investment company SIF Muntenia, which previously held a stake in Sicomed and sold it to Zentiva late last year, and a consortium of investors including Biofarm, a Bucharest-based manufacturer of herbal pharmaceuticals.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
